Iovance Biotherapeutics (NASDAQ:IOVA) jumps 18%, adding a cash balance to its market value
NEW YORK, July 15, 2026, 15:08 EDT Iovance Biotherapeutics (NASDAQ:IOVA) shares surged 18.2% to $4.645 by 3:01 p.m. EDT on Wednesday, adding about $319 million to the cancer-cell therapy maker’s…
Read the full articleYou might also wanna read
First Tracks Biotherapeutics price target raised by $14 at H.C. Wainwright, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Elutia to sell SimpliDerm business to Cellution Biologics for $11M
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Abivax: Wall Street Catches Up to the Data
Abivax stock surged over 40% after positive Phase 3 data on ulcerative colitis drug Obefazimod and a $920 million share offering that underw
Arcutis Biotherapeutics (NASDAQ:ARQT): High Growth Stock With a Strong Technical Setup
Arcutis Biotherapeutics (ARQT) shows strong growth with 97% EPS and 95% revenue increases. Its perfect technical rating and consolidation se
Revolution Medicines Is Up Nearly 140% in 2026. Is the Hot Biotech Stock Still a Buy?
The company recently wowed investors with clinical trial results.
Intellia Therapeutics price target raised by $5 at Wedbush, here's why
See the rest of the story here . thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The F
Comments
Sign in to join the conversation.
No comments yet. Be the first.